Clarity in cell line development

Solentim reports continued strong growth in 2019

NEWS – Bournemouth, UK – 8th August 2019: Solentim, the innovator and World leader in Cell Line Development instrumentation, is pleased to announce that it achieved very strong revenue growth and financial results for the first half of 2019. Commenting on the performance, Dr Ian Taylor, Chief Commercial Officer noted “Our results are in line with …

Read more Solentim reports continued strong growth in 2019

Solentim in the Press: “Fast-Tracking Cell-Line Development”, BioCompare

“Protein pharmaceuticals represent a multibillion-dollar market, but deciphering the most suitable biotherapeutic-producing cell lines is a substantial manufacturing bottleneck”, writes Lauren Tanabe for a recent article published by BioCompare. CHO cells have been the expression system of choice for producing biological therapies for several decades; they are accepted by the FDA, easy to work with, …

Read more Solentim in the Press: “Fast-Tracking Cell-Line Development”, BioCompare

Solentim, along with partner ATUM, will present at the forthcoming Cell Line Development and Engineering US Conference

Solentim, a global leader in cell line development instrumentation, will be speaking and exhibiting at the Cell Line Development and Engineering Conference US, which returns to San Francisco later this month. We are excited that our co-marketing and collaboration partner ATUM will also be speaking and exhibiting at the event. The aim of the conference …

Read more Solentim, along with partner ATUM, will present at the forthcoming Cell Line Development and Engineering US Conference

Removal of fluorescence screening of clones in cell line development: a paradigm shift

Dr Ian Taylor, Chief Commercial Officer, Solentim, blogs on his views following the recent ESACT conference in Copenhagen. Having just returned from ESACT in Copenhagen, I was impressed once again with the extremely high quality of the poster sessions throughout the event, presented by top level scientists working in labs around the world. One aspect …

Read more Removal of fluorescence screening of clones in cell line development: a paradigm shift

Solentim will be exhibiting at Hanson Wades’s 5th Precision CRISPR Genome Editing Congress in Boston

Solentim, a global leader in cell line development instrumentation is pleased to announce it will be attending and exhibiting at the 5th Precision CRISPR Genome Editing Congress, 21st-23rd May, in Boston, USA The conference will focus on the delivery of more precise, efficient and safer genome editing to optimise drug discovery, functional screening and CRISPR-based cell …

Read more Solentim will be exhibiting at Hanson Wades’s 5th Precision CRISPR Genome Editing Congress in Boston